Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Autosomal dominant hypocalcemia with Bartter syndrome due to a novel activating mutation of calcium sensing receptor, Y829C

  • Choi, Keun Hee (Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Shin, Choong Ho (Division of Endocrinology and Metabolism, Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Yang, Sei Won (Division of Endocrinology and Metabolism, Department of Pediatrics, Seoul National University Children's Hospital) ;
  • Cheong, Hae Il (Department of Pediatrics, Seoul National University Children's Hospital)
  • Received : 2013.09.15
  • Accepted : 2013.10.21
  • Published : 2015.04.15
Download PDF
⟨ Previous Next ⟩

Abstract

The calcium sensing receptor (CaSR) plays an important role in calcium homeostasis. Activating mutations of CaSR cause autosomal dominant hypocalcemia by affecting parathyroid hormone secretion in parathyroid gland and calcium resorption in kidney. They can also cause a type 5 Bartter syndrome by inhibiting the apical potassium channel in the thick ascending limb of the loop of Henle in the kidney. This study presents a patient who had autosomal dominant hypocalcemia with Bartter syndrome due to an activating mutation Y829C in the transmembrane domain of the CaSR. Symptoms of hypocalcemia occurred 12 days after birth and medication was started immediately. Medullary nephrocalcinosis and basal ganglia calcification were found at 7 years old and at 17 years old. Three hypercalcemic episodes occurred, one at 14 years old and two at 17 years old. The Bartter syndrome was not severe while the serum calcium concentration was controlled, but during hypercalcemic periods, the symptoms of Bartter syndrome were aggravated.

Keywords

References

  1. Shoback D. Clinical practice. Hypoparathyroidism. N Engl J Med 2008;359:391-403. https://doi.org/10.1056/NEJMcp0803050
  2. Lienhardt-Roussie A, Linglart A. Hypoparathyroidism in children. In: Licata AA, Lerma EV. Diseases of the parathyroid glands. New York: Springer, 2012;299-310.
  3. D'Souza-Li L. The calcium-sensing receptor and related diseases. Arq Bras Endocrinol Metabol 2006;50:628-39. https://doi.org/10.1590/S0004-27302006000400008
  4. Garrett JE, Capuano IV, Hammerland LG, Hung BC, Brown EM, Hebert SC, et al. Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem 1995;270:12919-25. https://doi.org/10.1074/jbc.270.21.12919
  5. Hebert SC, Brown EM, Harris HW. Role of the Ca(2+)-sensing receptor in divalent mineral ion homeostasis. J Exp Biol 1997;200(Pt 2):295-302.
  6. Chattopadhyay N, Baum M, Bai M, Riccardi D, Hebert SC, Harris HW, et al. Ontogeny of the extracellular calcium-sensing receptor in rat kidney. Am J Physiol 1996;271(3 Pt 2):F736-43. https://doi.org/10.1152/ajpcell.1996.271.3.C736
  7. Brown EM, Hebert SC. Calcium-receptor-regulated parathyroid and renal function. Bone 1997;20:303-9. https://doi.org/10.1016/S8756-3282(97)00002-1
  8. Pollak MR, Brown EM, Chou YH, Hebert SC, Marx SJ, Steinmann B, et al. Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993;75:1297-303. https://doi.org/10.1016/0092-8674(93)90617-Y
  9. Pearce SH, Williamson C, Kifor O, Bai M, Coulthard MG, Davies M, et al. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 1996;335:1115-22. https://doi.org/10.1056/NEJM199610103351505
  10. Watanabe S, Fukumoto S, Chang H, Takeuchi Y, Hasegawa Y, Okazaki R, et al. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet 2002;360:692-4. https://doi.org/10.1016/S0140-6736(02)09842-2
  11. Vezzoli G, Arcidiacono T, Paloschi V, Terranegra A, Biasion R, Weber G, et al. Autosomal dominant hypocalcemia with mild type 5 Bartter syndrome. J Nephrol 2006;19:525-8.
  12. Hebert SC. Bartter syndrome. Curr Opin Nephrol Hypertens 2003;12:527-32. https://doi.org/10.1097/00041552-200309000-00008
  13. Wang WH, Lu M, Hebert SC. Cytochrome P-450 metabolites mediate extracellular Ca(2+)-induced inhibition of apical K+ channels in the TAL. Am J Physiol 1996;271(1 Pt 1):C103-11. https://doi.org/10.1152/ajpcell.1996.271.1.C103
  14. Raue F, Pichl J, Dorr HG, Schnabel D, Heidemann P, Hammersen G, et al. Activating mutations in the calcium-sensing receptor: genetic and clinical spectrum in 25 patients with autosomal dominant hypocalcaemia - a German survey. Clin Endocrinol (Oxf) 2011;75:760-5. https://doi.org/10.1111/j.1365-2265.2011.04142.x
  15. Lienhardt A, Bai M, Lagarde JP, Rigaud M, Zhang Z, Jiang Y, et al. Activating mutations of the calcium-sensing receptor: management of hypocalcemia. J Clin Endocrinol Metab 2001;86:5313-23. https://doi.org/10.1210/jcem.86.11.8016

Cited by

  1. GENETICS IN ENDOCRINOLOGY: Gain and loss of function mutations of the calcium-sensing receptor and associated proteins: current treatment concepts vol.174, pp.5, 2016, https://doi.org/10.1530/eje-15-1028
  2. Osteomalacia in a Case of Adult-Onset Bartter Syndrome vol.5, pp.3, 2015, https://doi.org/10.12890/2018_000764
  3. De novo a novel variant of CaSR gene in a neonate with congenital hypoparathyroidism vol.23, pp.2, 2015, https://doi.org/10.6065/apem.2018.23.2.107
  4. The Calcium-Sensing Receptor Increases Activity of the Renal NCC through the WNK4-SPAK Pathway vol.29, pp.7, 2015, https://doi.org/10.1681/asn.2017111155
  5. A cell function study on calcium regulation of a novel calcium-sensing receptor mutation (p.Tyr825Phe) vol.26, pp.1, 2015, https://doi.org/10.6065/apem.2040022.011